Deal Capsule

Deal Capsule

Transactions in Chemicals & Pharmaceuticals

Transactions in Chemicals & Pharmaceuticals

M&A activity remains fairly stable in both sectors. Two announced life sciences deals in HY1 2017 crossed the $20 billion mark.

 

Connect with us

KPMG's new digital platform

KPMG International has created a state of the art digital platform that enhances your experience, optimized to discover new and related content.

Deal Capsule - Transactions in Pharmaceuticals April 2017

Pharmaceutical M&A turned its focus on biotech targets to seize late-stage assets. Generics and animal health were further key areas of interest.

 
Read more

Deal Capsule - Transactions in Chemicals April 2017

In chemicals, several mega deals are close to completion. Activity was spread across the value chain with a focus on agrochemicals. PE activity was subdued due to high valuations.

 
Read more